Nicolas Demartines
Amministratore Delegato presso Centre Hospitalier Universitaire Vaudois
Provenienza dei contatti di primo grado di Nicolas Demartines
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Centre Hospitalier Universitaire Vaudois
Centre Hospitalier Universitaire Vaudois Hospital/Nursing ManagementHealth Services Centre Hospitalier Universitaire Vaudois is a university hospital located in Lausanne, CH. The SwitzerlandUV is also a renowned center of medical education and research, collaborating with the Faculty of Biology and Medicine of the University of Lausanne and the Swiss Federal Institute of Technology in Lausanne (EPFL). It has 16 clinical and medico-technical departments and is known for its academic achievements in healthcare, research, and teaching. The vast campus in the lake region is home to these institutions. The CEO of the Swiss company is Nicolas Demartines.
3
| Private Company | Hospital/Nursing Management | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Nicolas Demartines tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
GALENICA AG | Medical Distributors | Director/Board Member | |
University of Pavia | College/University | Doctorate Degree | |
Swiss Federal Institute of Technology | College/University | Corporate Officer/Principal | |
ONWARD MEDICAL N.V. | Miscellaneous Commercial Services | Founder | |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | Biotechnology | Founder | |
Swiss Society For Allergology & Immunology | President | ||
Fondation Soins Intensifs & Centre Brûlés Centre Hospitalier
Fondation Soins Intensifs & Centre Brûlés Centre Hospitalier Hospital/Nursing ManagementHealth Services Fondation Soins Intensifs & Centre Brûlés Centre Hospitalier is a medical services provider based in Lausanne, Switzerland. The Swiss company provides medical services and is ultimately controlled by the Government of Switzerland. | Hospital/Nursing Management | Corporate Officer/Principal | |
Anergis SA
Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Pharmaceuticals: Generic | Founder | |
University of Lausanne | College/University | Doctorate Degree | |
Speedel Pharma AG
Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Swissmedic
Swissmedic Miscellaneous Commercial ServicesCommercial Services Swissmedic is the national authorisation and supervisory authority for drugs and medical products. It provides clinical laboratory testing services. The company is headquartered in Bern, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
Swiss Society of Hypertension | Corporate Officer/Principal | ||
European Society of Hypertension | Treasurer | ||
European Research Council
European Research Council Investment Trusts/Mutual FundsMiscellaneous The European Research Council is an organization that provides grants for research projects. The organization is based in Brussels, Belgium. As a grantee, individuals are required to submit scientific and financial reports for assessment by ERC Scientific Officers. The organization emphasizes the importance of research ethics and compliance with legislation, disciplinary norms, and protection of research subjects. The responsibility for ethics lies with the individuals conducting the research, while the formal accountability lies with the signatory of the Grant Agreement, the Host Institution. | Investment Trusts/Mutual Funds | Treasurer | |
Swiss Society of Nephrology | Corporate Officer/Principal | ||
University of Colorado Health Sciences Center | College/University | Corporate Officer/Principal | |
NeuroRestore
NeuroRestore Pharmaceuticals: MajorHealth Technology NeuroRestore is a platform of symptom-relieving drug candidates for disease states in which cognitive ability is impaired, such as Alzheimer's disease, sleep apnea, traumatic brain injury, and Parkinson's disease. NeuroRestore is based in Lausanne, Switzerland. The Swiss company stimulates specific signaling pathways in the central nervous system known as neurotrophins, which play a crucial role in the function of nerve cells. The most well-known neurotrophins are NGF (nerve growth factor) and BDNF (brain-derived neurotrophic factor). NeuroRestore's drug candidates enhance communication between nerve cells and improve cognitive ability. The private company's leading drug candidate, ACD856, has recently completed clinical phase I studies and demonstrated positive effects. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
Svizzera | 17 |
Italia | 2 |
Paesi Bassi | 2 |
Belgio | 2 |
Stati Uniti | 2 |
Settori
Health Technology | 8 |
Consumer Services | 5 |
Commercial Services | 3 |
Distribution Services | 2 |
Health Services | 2 |
Posizioni
Corporate Officer/Principal | 10 |
Director/Board Member | 9 |
President | 3 |
Founder | 3 |
Treasurer | 2 |
Contatti più connessi
Insiders | |
---|---|
Michel Burnier | 13 |
Grégoire Courtine | 6 |
Francois Spertini | 4 |
- Borsa valori
- Insiders
- Nicolas Demartines
- Connessioni Società